Tactic Links - Organic Traffic Booster - Home

Path: Home > List > Load (dndi.org)

domain	dndi.org
summary	DNDi is a nonprofit organization dedicated to developing new treatments for diseases affecting the poorest populations in the world. They focus on neglected tropical diseases, pediatric HIV, and other global health challenges. DNDi operates through an integrated strategy that includes research and development (R&D), clinical trials, drug discovery, partnerships, advocacy, and transparency. Some of their main areas of work include: 1. Developing new treatments for sleeping sickness, visceral leishmaniasis, cutaneous leishmaniasis, Chagas disease, filariasis: river blindness, mycetoma, pediatric HIV, and cryptococcal meningitis. 2. Supporting research on antimicrobial resistance, climate change impacts, AI and new technologies, networks, partnerships, open access R&D (OAR), and pro-access policies. 3. Fostering gender equity in the biomedical field and promoting children's health. 4. Engaging with stakeholders at local, national, and global levels to ensure that their work is transparent and accessible. 5. Promoting the development of new treatments for diseases like Chagas disease, filariasis: river blindness, mycetoma, pediatric HIV, and cryptococcal meningitis, which require more attention from the biomedical community. 6. Encouraging open and collaborative R&D (OAR) by building partnerships with various stakeholders in the field. 7. Developing a transparent RD cost model and advocating for pro-access policies to ensure that the most vulnerable populations have access to new treatments. 8. Focusing on research, development, clinical trials, registration, access, and advocacy to facilitate the delivery of treatments to affected populations. 9. Engaging in partnerships with various stakeholders at national, regional, and global levels to create a more robust network for disease elimination. 10. Working towards eliminating sleeping sickness, filariasis: river blindness, mycetoma, pediatric HIV, Chagas disease, and cryptococcal meningitis through the deployment of innovative drugs in endemic regions. 11. Supporting children's health by focusing on gender equity, climate change impacts, AI and new technologies, networks, partnerships, open access R&D (OAR), transparency of RD costs, pro-access policies, and advocacy for global health initiatives. 12. Investing in research and development (R&D) projects through their RD portfolio to discover new treatments for neglected diseases affecting the poorest populations worldwide. 13. Focusing on clinical trials, registration, access, and advocacy to facilitate the delivery of treatments to affected populations. 14. Providing resources for open and collaborative R&D (OAR), transparency of RD costs, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, and other relevant topics in the biomedical field. 15. Promoting transparency in research and development costs and advocating for pro-access policies to ensure that the most vulnerable populations have access to new treatments. 16. Focusing on research, development, clinical trials, registration, access, advocacy to facilitate the delivery of treatments to affected populations. 17. Developing resources for open and collaborative R&D (OAR), transparency of RD costs, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, and other relevant topics in the biomedical field. 18. Encouraging open and collaborative research, development, clinical trials, registration, access, advocacy to ensure that the most vulnerable populations have access to new treatments. 19. Focusing on drug discovery, translational research, clinical trials, registration, access, advocacy, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, open and collaborative R&D (OAR), transparency of RD costs, and other relevant topics in the biomedical field. 20. Promoting drug discovery, translational research, clinical trials, registration, access, advocacy, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, open and collaborative R&D (OAR), transparency of RD costs, and other relevant topics in the biomedical field. 21. Supporting research and development projects through their RD portfolio to discover innovative drugs for neglected diseases affecting the poorest populations worldwide. 22. Focusing on clinical trials, registration, access, advocacy, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, open and collaborative R&D (OAR), transparency of RD costs, and other relevant topics in the biomedical field. 23. Encouraging open and collaborative research and development through their OAR strategy to ensure that the most vulnerable populations have access to new treatments. 24. Focusing on drug discovery, translational research, clinical trials, registration, access, advocacy, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, open and collaborative R&D (OAR), transparency of RD costs, and other relevant topics in the biomedical field. 25. Promoting drug discovery, translational research, clinical trials, registration, access, advocacy, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, open and collaborative R&D (OAR), transparency of RD costs, and other relevant topics in the biomedical field. 26. Supporting drug discovery projects through their RD portfolio to discover innovative drugs for neglected diseases affecting the poorest populations worldwide. 27. Focusing on clinical trials, registration, access, advocacy, pro-access policies, children's health, gender equity, climate change impacts, AI and new technologies, networks, partnerships, open and collaborative R&D (OAR), transparency of RD costs, and other relevant topics in the biomedical field. 28. Encouraging open and collaborative research, development, clinical trials, registrationt Tend
title	DNDi – Best science for the most neglected
description	DNDi has created medical history for neglected patients, globally. Since 2003, we have developed 12 affordable treatments for 6 deadly diseases, saving millions of lives.
keywords	treatments, treatment, diseases, research, work, disease, news, leishmaniasis, platform, people, chagas, dengue, access, partners, press, working, sleeping
upstreams	msf.org
downstreams
nslookup	A 84.16.78.12
screenshot
created	2024-02-26
updated	2024-02-26